Invention Grant
- Patent Title: 1:1 adducts of sickle hemoglobin
- Patent Title (中): 1:1镰刀血红蛋白加合物
-
Application No.: US14167632Application Date: 2014-01-29
-
Publication No.: US09248199B2Publication Date: 2016-02-02
- Inventor: Brian W. Metcalf
- Applicant: Global Blood Therapeutics, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: GLOBAL BLOOD THERAPEUTICS, INC.
- Current Assignee: GLOBAL BLOOD THERAPEUTICS, INC.
- Current Assignee Address: US CA South San Francisco
- Agency: Foley & Lardner LLP
- Main IPC: A61K31/4155
- IPC: A61K31/4155 ; A61K31/5377 ; A61K47/48 ; A61K31/444 ; A61K31/4439 ; A61K31/5386

Abstract:
Provide herein are 1:1 adducts of sickle hemoglobin (HbS) and a compound of formula (I), as defined herein, suitable as modulators of HbS, and methods for their use in treating disorders mediated by hemoglobin and disorders that would benefit from tissue and/or cellular oxygenation.
Public/Granted literature
- US20150209443A1 1:1 ADDUCTS OF SICKLE HEMOGLOBIN Public/Granted day:2015-07-30
Information query
IPC分类: